Stock Price
4.97
Daily Change
-0.03 -0.60%
Monthly
-8.47%
Yearly
2.05%
Q1 Forecast
4.90

Silence Therapeutics reported $5.6M in Selling and Administration Expenses for its fiscal quarter ending in September of 2024.





Selling And Administration Expenses Change Date
AstraZeneca USD 4.61B 4.46B Dec/2025
Autolus Therapeutics Ltd USD 27.96M 1.58M Jun/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Novartis USD 3.31B 134M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Silence Therapeutics USD 5.6M 312K Sep/2024